Ulisse Biomed Spa
MIL:UBM

Watchlist Manager
Ulisse Biomed Spa Logo
Ulisse Biomed Spa
MIL:UBM
Watchlist
Price: 0.974 EUR -0.41%
Market Cap: 21.5m EUR
Have any thoughts about
Ulisse Biomed Spa?
Write Note

Ulisse Biomed Spa
Investor Relations

Ulisse BioMed SpA is an Italian healthcare biotech company. The company is headquartered in Udine, Udine. The company went IPO on 2021-08-06. The firm focuses on creating new and transformative diagntostic platforms and products. The company creates diagnostic systems that can reach people directly and help increasing the frequency of health monitoring. Its platforms include Sagitta, NanoHybrid and Aptavir. Sagitta is a molecular diagnostics technology platform, capable of detecting and characterizing nucleic acids of viral, bacterial and eukaryotic origin. Sagitta is used to develop assays for Respiratory Viral Panel, Sexually Transmitted Diseases, Infectious Diseases and Oncology. NanoHybrid can be implemented not only to develop diagnostic solutions but also in the field of theranostics: the integration of a diagnostic method with a specific therapeutic intervention aimed at maximizing the effectiveness of the drug, as well as vaccine/immunoterapies monitoring. Aptavir is a platform for the identification and production of antiviral molecules.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Earnings Calls

No Earnings Calls Available

Management

Mr. Nicola Basile
CEO & Director
No Bio Available
Ms. Bruna Marini
Co-founder, COO & Executive Director
No Bio Available
Mr. Rudy Ippodrino
Co-Founder & Chief Scientific Officer
No Bio Available
Mr. Ferdinando Giuliani
Head of Business Development
No Bio Available
Mr. Carlo Montenovesi
Executive Director
No Bio Available

Contacts

Address
UDINE
Udine
Via Cavour 20
Contacts
+390403757540
ulissebiomed.com